Abstract
Hyperglycaemia is a frequently diagnosed metabolic abnormality in the inpatient setting, either related to the case of known diabetes, previously undiagnosed diabetes or as a result of the acute or exacerbation of presenting chronic illness [1, 2]. Stress hyperglycaemia may also be induced by medications including steroids, inotropic agents, immunosuppressants and nutritional support via the enteral or parenteral route [1, 2]. Preoperative glycaemic imbalance and perioperative elevations of blood glucose are directly associated with poor prognosis [1–4], including increase in mortality, decrease in cardiovascular event-free survival, increase in resource utilisation and decrease in quality of life. Hyperglycaemia significantly influences hospital morbidity, including increase in the risk of infections, renal failure, prolonged mechanical ventilation and anaemia requiring blood transfusions, which subsequently extends the length of hospital stay [1–4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pichardo-Lowden A, Gabbay RA (2012) Management of hyperglycemia during the perioperative period. Curr Diab Rep 12:108–118
Wang CC, Reusch JE (2012) Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am J Cardiol 110:58B–68B
Kwon S, Thompson R, Dellinger P et al (2013) Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg 257:8–14
Sato H, Carvalho G, Sato T et al (2010) The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab 95:4338–4344
Landoni G, Augoustides JG, Guarracino F et al (2011) Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. HSR Proc Intensiv Care Cardiovasc Anesth 3:9–19
Landoni G, Rodseth RN, Santini F et al (2012) Randomized evidence for reduction of perioperative mortality. J Cardiothorac Vasc Anesth 26:764–772
Landoni G, Pisano A, Lomivorotov V et al (2016) Randomized evidence for reduction of perioperative mortality: an updated consensus process. J Cardiothorac Vasc Anesth doi:10.1053/j.jvca.2016.07.017
Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367
Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461
Wiener RS, Wiener DC, Larson RJ (2008) Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 300:933–944
Kansagara D, Fu R, Freeman M et al (2011) Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 154:268–282
Sathya B, Davis R, Taveira T, Whitlatch H, Wu WC (2013) Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract 102:8–15
NICE-SUGAR Study Investigators (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297
NICE-SUGAR Study Investigators, Finfer S, Liu B et al (2012) Hypoglycemia and risk of death in critically ill patients. N Engl J Med 20:1108–1118
Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139
Ooi YC, Dagi TF, Maltenfort M et al (2012) Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients. Neurosurgery 71:692–702
Haga KK, McClymont KL, Clarke S et al (2011) The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: a systematic review and meta-analysis. J Cardiothorac Surg 6:3
Hua J, Chen G, Li H et al (2012) Intensive intraoperative insulin therapy versus conventional insulin therapy during cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 26:829–834
Bhamidipati CM, LaPar DJ, Stukenborg GJ et al (2011) Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 141:543–551
Umpierrez G, Cardona S, Pasquel F et al (2015) Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care 38:1665–1672
Krinsley JS, Meyfroidt G, van den Berghe G et al (2012) The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care 15:151–160
Brange J, Langkjoer L (1993) Insulin structure and stability. Pharm Biotechnol 5:315–350
Welsh M, Scherberg N, Gilmore R et al (1986) Translational control of insulin biosynthesis. Evidence for regulation of elongation, initiation and signal-recognition-particle-mediated translational arrest by glucose. Biochem J 235:459–467
Wilden PA, Kahn CR, Siddle K et al (1992) Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. J Biol Chem 267:16660
Moghissi ES, Korytkowski MT, DiNardo M et al (2009) American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 32:1119–1131
Ahmed Z, Lockhart CH, Weiner M (2005) Advances in diabetic management: implications for anesthesia. Anesth Analg 100:666–669
Mazer M, Chen E (2009) Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis. Ann Emerg Med 53:259–263
Joshi GP, Chung F, Vann MA et al (2010) Society for Ambulatory Anesthesia. Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Analg 111:1378–1387
Qaseem A, Chou R, Humphrey LL, Shekelle P; Clinical Guidelines Committee of the American College of Physicians (2014) Inpatient glycemic control: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Am J Med Qual 29:95–98
Lazar HL, McDonnell M, Chipkin SR et al (2009) The Society of Thoracic Surgeons Practice Guideline Series: blood glucose management during adult cardiac surgery. Ann Thorac Surg 87:663–669
Wilson M, Weinreb J, Hoo GW (2007) Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 30:1005–1011
Kanji S, Buffie J, Hutton B et al (2005) Reliability of point-of care testing for glucose measurement in critically ill adults. Crit Care Med 33:2778–2785
Cryer PE, Axelrod L, Grossman AB et al (2009) Endocrine Society. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 94: 709–728
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Summary Table
Summary Table
Clinical summary | |||||
---|---|---|---|---|---|
Drugs | Indications | Cautions | Side effects | Dosage | Notes |
Insulin in intravenous infusion (regular human insulin or short-acting analogue) | Perioperative management of hyperglycaemia in patients with diabetes type 1/2 and excessive intraoperative hyperglycaemia in patients without previous history of diabetes | Severe risk of hypoglycaemia and hypokalaemia | Hypoglycaemia | Initial insulin infusion of 0.5–1 IU/h, then 0.3 IU/h increments or decrements depending on blood glucose level | Target intraoperative blood glucose level is 140–180 mg/dL |
Glucose level should be checked directly before surgery and every 1 h during and after the procedure | Hypokalaemia | Minor ambulatory procedures in diabetes type 2 can be performed without IV insulin | |||
[K+] should be verified before and after the procedure | Allergic reactions | In patients with a well-controlled diabetes type 2 treated with diet or oral agents, IV insulin is not obligatory | |||
Weight gain | |||||
Lipodystrophy |
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Krzych, Ł.J., Wybraniec, M.T. (2017). Role of Insulin in Reducing Mortality in the Perioperative Period. In: Landoni, G., Ruggeri, L., Zangrillo, A. (eds) Reducing Mortality in the Perioperative Period. Springer, Cham. https://doi.org/10.1007/978-3-319-46696-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-46696-5_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46695-8
Online ISBN: 978-3-319-46696-5
eBook Packages: MedicineMedicine (R0)